Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 1–12 of 124 articles · Check methods and identity
- Check methods and identity
What the 2026 marmoset study measured
ACE-031 is a larger engineered fusion protein. It joins the outer, signal-binding part of human activin receptor type IIB to the Fc region of a human antibody.
ACE-0312 sources (2016, 2026)
- Check methods and identity
How laboratories tested the identity of products labeled ACE-031
Authentic ACE-031 is a larger fusion protein consisting of a portion of the activin receptor type IIB and a human IgG1 Fc region. An analytical study published in May 2025, before the recent research window, asked whether products sold under that name contained the expected fusion protein.
ACE-0311 source (2025)
- Check methods and identity
What newer muscle imaging adds to the ACE-083 story
ACE-083 is a larger engineered fusion protein made from modified follistatin and the Fc region of a human antibody. It was designed to capture signals that restrict muscle growth near the muscle under study.
ACE-0832 sources (2022, 2026)
- Check methods and identity
What imaging revealed in the adipotide monkey experiment
Adipotide is an experimental peptide construct designed to reach the blood vessels that supply white fat and trigger the death of some of the cells lining those vessels. An older primate study asked whether changes on the scale corresponded to changes in the amount of fat tissue.
Adipotide1 source (2011)
- Check methods and identity
Why AOD-9604 safety findings depend on the formulation
AOD-9604 is a modified human growth hormone fragment studied in several formulations. The older clinical reports and FDA evaluation raise a practical question about how much can be learned from safety observations on one formulation.
AOD-96042 sources (2013, 2024)
- Check methods and identity
What the LAT8881 neuropathic pain crossover study measured
AOD-9604 is a 16-amino-acid growth hormone derivative that was later studied under the name LAT8881. An older randomized human study tested whether people with neuropathic pain reported a different level of pain while receiving LAT8881 than while receiving placebo.
AOD-96042 sources (2019, 2021)
- Check methods and identity
Why scientists measured both fat oxidation and body weight
AOD-9604 is a modified peptide from the end of human growth hormone. An older mouse study compared it with the full hormone and asked how changes in fat metabolism related to changes in body weight. The investigators measured body weight, the use of fat as fuel, and levels of circulating glycerol.
AOD-96042 sources (2001, 2024)
- Check methods and identity
What a diabetic mouse wound model could measure
ARA-290, also known as cibinetide, is a designed 11-amino-acid peptide modeled on a surface of erythropoietin. An older laboratory study, first published online in 2017, investigated how wounds in mice with genetic diabetes responded to the peptide.
ARA-2901 source (2017)
- Check methods and identity
What a 2026 rat experiment measured after blood flow returned
BPC-157 is a synthetic peptide containing 15 amino acids. In May 2026, researchers reported an experiment that asked whether it changed early signs of damage when blood flow returned to a rat's hind limb after a temporary interruption.
BPC-1571 source (2026)
- Check methods and identity
How a registered hamstring study plans to measure recovery
BPC-157 is an experimental 15-amino-acid peptide. A clinical trial registered in February 2026 proposes to study it in people with acute grade II hamstring strains confirmed by magnetic resonance imaging.
BPC-1571 source (2026)
- Check methods and identity
The trials designed to test cagrilintide on its own
Cagrilintide is an investigational, long-acting peptide that activates receptors for amylin and calcitonin. It is often discussed alongside semaglutide because they are being studied together as CagriSema.
Cagrilintide3 sources (2025, 2026)
- Check methods and identity
Which molecule does the name CJC-1295 No DAC describe?
CJC-1295 No DAC is commonly used as a label for modified growth hormone–releasing factor (1–29), or Mod GRF (1–29). The first question about a paper or catalog entry is whether that name refers to the same molecule in both places.
CJC-1295 No DAC1 source (2024)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
